Received Jun 25, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (PFIZER-BIONTECH)) | PFIZER\BIONTECH | 4 | GJ5342 | — |
The first five doses had minimal side effects, causing only minor discomfort for a couple of days; This is a spontaneous report received from a Consumer or other non HCP. An elderly patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 04Nov2022 as dose 4 (booster), single (Lot number: GJ5342) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: BNT162b2 (DOSE 1, lot number: ER8734), administration date: 01Apr2021, for covid-19 immunisation, reaction(s): "The first five doses had minimal side effects, causing only minor discomfort for a couple of days"; BNT162b2 (DOSE 2, lot number: EW0161), administration date: 22Apr2021, for covid-19 immunisation, reaction(s): "The first five doses had minimal side effects, causing only minor discomfort for a couple of days"; BNT162b2 (DOSE 3 (BOOSTER), lot number: FJ1620), administration date: 07Dec2021, for covid-19 immunisation, reaction(s): "The first five doses had minimal side effects, causing only minor discomfort for a couple of days". The following information was reported: DISCOMFORT (non-serious), outcome "unknown", described as "The first five doses had minimal side effects, causing only minor discomfort for a couple of days".; Sender's Comments: Linked Report(s) : US-PFIZER INC-202500122789 same patient and reporter, different dose and event;